Dr. Radek Wasiak and Prof. Dr. Thomas Wilke are thought & business leaders at Cytel, a leading provider of design and implementation services in the field of clinical trials and real-world evidence studies.
As Head of Real World and Advanced Analytics business unit, Radek oversees a team of 180+ staff who design, execute, and disseminate RWE and HEOR projects.
Thomas has 20+ years of experience in leading and conducting German and international RWE studies. He is Cytel’s Principal Investigator, academic researcher, and author of numerous health economics articles.
Thomas and Radek joined CELforPharma’s faculty in 2023 upon recommendation of other Market Access faculty members who applauded them for their RWE expertise.
Learn from from Dr. Paul Craddy & Dr. Graham Foxon at the below course: